Approval for fertility media in Australia

As one of the first companies outside Australia, Vitrolife has received sales approval from the Australian Medical Products Agency, TGA, for its fertility media. This registration approval means that Vitrolife can now market its products to all clinics on the same terms as local suppliers. TGA has after review also issued a certificate regarding Vitrolife’s quality system.

“The market in Australia is important as it is an opinion leader in large parts of Asia and can form a bridgehead for continued expansion in the Asia/Pacific region, which today has the fastest growth”, says Nils Sellbom, Vitrolife’s Sales Director. ”We also see that a great deal of pioneering research within IVF and stem cells originates in clinics and universities in Australia.”

The Australian Medical Products Agency TGA has also issued a so-called “Conformity Assessment Certificate” for Vitrolife’s plant in Kungsbacka. The certificate is based on an extensive examination of the business, and recognition means that Vitrolife has a full quality management system applied from the design until final inspection of the ready medical device.


October 30, 2007
Kungsbacka, Sweden

Magnus Nilsson
CEO










Queries should be addressed to:
Magnus Nilsson, CEO, phone +46 31 721 80 00 or +46 708 22 80 61.
Anna Ahlberg, CFO, phone +46 31 721 80 13 or +46 708 22 80 13.